Treating Depression and Enhancing Locomotor Recovery Post-stroke
治疗抑郁症并促进中风后运动恢复
基本信息
- 批准号:9260016
- 负责人:
- 金额:$ 19.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvantAerobic ExerciseAffectBrainClinical TreatmentComplexDataDepressed moodDevelopmentDiseaseDisease remissionEffectivenessEvaluationFoundationsFundingFutureGoalsGuidelinesHamilton Rating Scale for DepressionIndividualInterventionInvestigationLocomotor RecoveryMajor Depressive DisorderMeasuresMental DepressionMethodsMono-SMotivationNeuronal PlasticityOutcomePersonsPharmacological TreatmentPhasePrevalenceRandomizedRehabilitation OutcomeRehabilitation therapyResearchSamplingSeveritiesSouth CarolinaStrokeTestingTherapeutic TrialsTrainingTreatment EfficacyWalkingWorkbasechronic strokedepressive symptomsdesigneffective therapyexercise trainingexperimental studyfollow-upfunctional gainfunctional outcomesimprovedimproved outcomenegative affectneuromechanismneuropsychiatrynovel strategiespost strokepost stroke depressionpredicting responserehabilitation strategyrelating to nervous systemrepetitive transcranial magnetic stimulationresponsestroke recoverystroke survivortreatment effecttreatment responsewalking speedwhite matter
项目摘要
Depression is the most common neuropsychiatric manifestation following stroke and current treatments are
largely ineffective. Depression has both direct and indirect effects on response to rehabilitation treatment; thus
subjects with post-stroke depression (PSD) are routinely excluded from rehabilitation trials and treatment
options for these individuals are extremely limited. We propose to determine the impact of two known anti-depressive
treatments shown to be effective in non-stroke related depression - aerobic exercise training (AET)
and repetitive transcranial magnetic stimulation (rTMS) - on post-stroke depressive symptoms. Further, we will
determine if depression limits gains in walking function in response to treatment and if successful reduction in
depressive symptoms facilitates improved walking.
This project is based on the premise that depression negatively affects the potential for the brain to adapt in
response to treatment such that rehabilitation may not produce the same brain changes that it does in non-depressed
individuals. We propose that effective treatment for PSD would result in a virtuous cycle where
reducing depression enhances brain changes, thereby facilitating functional gains. That is, effectively treating
depression will make the brain better able to recover from stroke. Furthermore, in addition to its beneficial
effects on depression, AET is known to improve post-stroke walking, thus providing an attractive option for
treating depression as well as an established vehicle to study the effects of PSD on response to locomotor
rehabilitation.
The experiments proposed as part of this project are designed to address critical questions related to the: 1)
effects of AET and/or rTMS on depressive symptoms; 2) potential for PSD to limit improvements in locomotor
function; 3) impact of combining AET and rTMS treatments; and 4) relationship between baseline subject
attributes and response to treatment(s). Successful completion of this project will provide a foundation for
larger scale therapeutic trials to establish the effectiveness of AET and/or rTMS on post-stroke depression and
walking as well as identify the mechanisms that may be responsible for the changes that occur in response to
treatment.
抑郁症是中风后最常见的神经精神症状,目前的治疗方法是
大部分无效。抑郁症对康复治疗的反应有直接和间接的影响;因此,
卒中后抑郁(PSD)患者通常被排除在康复试验和治疗之外,
这些人的选择极为有限。我们建议确定两种已知的抗抑郁药的影响,
对非中风相关抑郁症有效的治疗-有氧运动训练(AET)
和重复经颅磁刺激(rTMS)-中风后抑郁症状。此外,我们将
确定抑郁症是否限制了治疗后行走功能的增加,
抑郁症状有助于改善行走。
这个项目是基于这样一个前提,即抑郁症会对大脑适应环境的潜力产生负面影响。
对治疗的反应,使康复可能不会产生相同的大脑变化,它在非抑郁症
个体我们认为,有效的治疗PSD将导致一个良性循环,
减少抑郁会促进大脑的变化,从而促进功能的改善。即有效治疗
抑郁症会使大脑更好地从中风中恢复过来。此外,除了其有益的
对抑郁症的影响,AET已知可改善中风后行走,因此为治疗中风提供了一个有吸引力的选择。
治疗抑郁症以及建立车辆,以研究PSD对运动反应的影响
康复活动.
作为本项目的一部分,提出的实验旨在解决与以下方面相关的关键问题:1)
AET和/或rTMS对抑郁症状的影响; 2)PSD可能限制运动功能的改善
功能; 3)AET和rTMS联合治疗的影响;和4)基线受试者之间的关系
属性和对治疗的反应。该项目的成功完成将为
更大规模的治疗试验,以确定AET和/或rTMS对卒中后抑郁的有效性,
步行以及识别可能负责响应于
治疗
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chris Gregory其他文献
Chris Gregory的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chris Gregory', 18)}}的其他基金
Muscle power training to improve depression and walking post-stroke
肌肉力量训练可改善抑郁症和中风后行走
- 批准号:
10174988 - 财政年份:2018
- 资助金额:
$ 19.66万 - 项目类别:
Muscle power training to improve depression and walking post-stroke
肌肉力量训练可改善抑郁症和中风后行走
- 批准号:
10433884 - 财政年份:2018
- 资助金额:
$ 19.66万 - 项目类别:
Treating Depression and Enhancing Locomotor Recovery Post-stroke
治疗抑郁症并促进中风后运动恢复
- 批准号:
8663389 - 财政年份:2014
- 资助金额:
$ 19.66万 - 项目类别:
Skeletal Muscle Plasticity As An Indicator of Functional Performance Post-Stroke
骨骼肌可塑性作为中风后功能表现的指标
- 批准号:
8594581 - 财政年份:2013
- 资助金额:
$ 19.66万 - 项目类别:
Skeletal Muscle Plasticity As An Indicator of Functional Performance Post-Stroke
骨骼肌可塑性作为中风后功能表现的指标
- 批准号:
8990852 - 财政年份:2013
- 资助金额:
$ 19.66万 - 项目类别:
Skeletal Muscle Plasticity As An Indicator of Functional Performance Post-Stroke
骨骼肌可塑性作为中风后功能表现的指标
- 批准号:
8825930 - 财政年份:2013
- 资助金额:
$ 19.66万 - 项目类别:
Treating Depression and Enhancing Locomotor Recovery Post-stroke
治疗抑郁症并促进中风后运动恢复
- 批准号:
9060348 - 财政年份:
- 资助金额:
$ 19.66万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 19.66万 - 项目类别: